Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events

Umut Uyan1

  • 1Department of Cardiology, İzmir Ödemiş State Hospital, İzmir, TUR.

Cureus
|November 29, 2023
PubMed

Insights

The HEART score demonstrated higher effectiveness than the HEAR score in identifying patients at high risk for major adverse cardiovascular events (MACE) within 30 days in the emergency department.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Risk Stratification

Background:

  • Effective risk stratification for acute coronary syndrome (ACS) in the emergency department (ED) is crucial for patient management and resource allocation.
  • The HEAR and HEART scores are tools used to assess short-term risk of major adverse cardiovascular events (MACE).

Purpose of the Study:

  • To compare the diagnostic accuracy of the HEAR score versus the HEART score for predicting 30-day MACE in patients presenting with chest pain.
  • To evaluate the utility of these scores in optimizing emergency department workflows.

Main Methods:

  • A prospective study involving 230 patients presenting to the ED with chest pain.
  • Calculation of HEAR and HEART scores, with MACE defined as MI, revascularization, death, cardiac arrest, cardiogenic shock, or arrhythmias within 30 days.
  • Receiver Operating Characteristic (ROC) analysis to determine optimal threshold values and compare sensitivity and specificity.

Main Results:

  • Out of 230 patients, 56 (24.3%) experienced MACE.
  • An optimal threshold of ≤3 for both scores yielded a sensitivity of 0.77 and specificity of 0.78 for the HEAR score.
  • The HEART score achieved a sensitivity of 0.82 and specificity of 0.77 at the same threshold.

Conclusions:

  • Both HEAR and HEART scoring systems are valuable tools for managing chest pain patients in the ED.
  • The HEART score exhibited superior performance in predicting 30-day MACE compared to the HEAR score.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
167
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
2.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96